Point72 Asset Management’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Other funds holding XENT
DM
FLAM
PC
Point72 Asset Management's XENT Position: Q1 2020 in Review
Point72 Asset Management sold out of Intersect ENT, Inc (XENT) in Q1 2020, closing a stake of 1,565,800 shares — an estimated $39M sold.
Point72 Asset Management first reported a position in XENT in Q2 2015 and held it in 13 quarters. The position peaked at $56M in Q2 2019. 121 funds tracked by Wall St. Rank hold XENT as of Q1 2020.
- Point72 Asset Management reported no remaining Intersect ENT, Inc position as of Q1 2020 after selling out during the quarter.
- Point72 Asset Management sold 1,565,800 Intersect ENT, Inc shares in Q1 2020, an estimated $39M.
- Point72 Asset Management first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 13 quarters.
- Point72 Asset Management's Intersect ENT, Inc position peaked at $56M in Q2 2019.
- 121 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2020.
Based on Point72 Asset Management's 13F filing for Q1 2020, filed 15 May 2020.